A Perspective on RNAi-Based Biopesticides

• Published in: Frontiers in plant science Vol. 11; p. 51
• Main Authors: Fletcher, Stephen J, Reeves, Philip T, Hoang, Bao Tram, Mitter, Neena
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 12.02.2020
• Subjects: biopesticide; crop protection; dsRNA; Plant Science; RNAi; topical application; biopesticide; dsRNA; RNAi; crop protection; topical application
• ISSN: 1664-462X; 1664-462X
• DOI: 10.3389/fpls.2020.00051

Sustainable agriculture relies on practices and technologies that combine effectiveness with a minimal environmental footprint. RNA interference (RNAi), a eukaryotic process in which transcript expression is reduced in a sequence-specific manner, can be co-opted for the control of plant pests and pathogens in a topical application system. Double-stranded RNA (dsRNA), the key trigger molecule of RNAi, has been shown to provide protection without the need for integration of dsRNA-expressing constructs as transgenes. Consequently, development of RNA-based biopesticides is gaining momentum as a narrow-spectrum alternative to chemical-based control measures, with pests and pathogens targeted with accuracy and specificity. Limitations for a commercially viable product to overcome include stable delivery of the topically applied dsRNA and extension of the duration of protection. In addition to the research focus on delivery of dsRNA, development of regulatory frameworks, risk identification, and establishing avoidance and mitigation strategies is key to widespread deployment of topical RNAi technologies. Once in place, these measures will provide the crop protection industry with the certainty necessary to expend resources on the development of innovative dsRNA-based products. Readily evident risks to human health appear minimal, with multiple barriers to uptake and a long history of consumption of dsRNA from plant material. Unintended impacts to the environment are expected to be most apparent in species closely related to the target. Holistic design practices, which incorporate bioinformatics-based dsRNA selection along with experimental testing, represent important techniques for elimination of adverse impacts.